Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aclaris Therapeutics Sells OLUMIANT Royalties And Milestones To OMERS Life Sciences For Up To $31.5M

Author: Benzinga Newsdesk | July 16, 2024 04:03pm

- Non-Dilutive Transaction Strengthens Balance Sheet to Support Strategic Priorities -

- $26.5 Million Upfront Plus Up to $5.0 Million Milestone -

Posted In: ACRS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist